Psychological and Cognitive Function: Predictors of Adherence with Cholesterol Lowering Treatment

Annals of Behavioral Medicine

Volumn 27, Issue 2, 2004, Pages 117-124

  Stilley, Carol S ^a,b,c   Sereika, Susan ^a   Muldoon, Matthew F ^b   Ryan, Christopher M ^b   Dunbar Jacob, Jacqueline ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL;

ADULT; ANXIETY DISORDER; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL RESEARCH; COGNITION; CONSCIENCE; DEPRESSION; DEPTH PERCEPTION; FEMALE; FIVE FACTOR THEORY OF PERSONALITY; HUMAN; HUMAN EXPERIMENT; INTELLIGENCE QUOTIENT; MALE; MENTAL CAPACITY; MOOD; NEUROPSYCHOLOGICAL TEST; NORMAL HUMAN; PATIENT COMPLIANCE; PERSONALITY; PSYCHOLOGICAL ASPECT; REGRESSION ANALYSIS; RELIABILITY; STATISTICAL ANALYSIS; THEORY; VARIANCE;

EID: 1642413628     PISSN: 08836612     EISSN: None     Source Type: Journal    
DOI: 10.1207/s15324796abm2702_6     Document Type: Article

References (29)

1. Dunbar-Jacob J, Sereika S, Rohay JM, Burke LE, Kwoh CK: Predictors of adherence: Differences by measurement method. 6th Annual Scientific Sessions of the Society of Behavioral Medicine. San Diego, CA: 1995.
2. Dunbar-Jacob JM, Mortimer-Stephens MK: Treatment adherence in chronic disease. Journal of Clinical Epidemiology. 2001, 54:S57-S60.
3. Muldoon MF, Ryan CM, Matthews KA, Manuck SB: Serum cholesterol and intellectual performance. Psychosomatic Medicine. 1997, 59:382-387.
4. Muldoon MF, Ryan CM, Flory JD, Matthews KA, Manuck SB: Effects of Lovastatin on cognitive functioning. American Journal of Medicine. 2000, 108:538-546.
5. DiMatteo MR, Lepper HS, Croghan TW: Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence. Archives of Internal Medicine. 2000, 160:2101-2107.
6. Malassiotis A, Nahas-Lopez V, Chung WY, et al.: Factors associated with adherence to antiretroviral medication in HIV-infected patients. International Journal of STD & AIDS. 2002, 13:301-310.
7. Wang PS, Bohn RL, Knight E, et al.: Noncompliance with antihypertensive medications: The impact of depressive symptoms and psychosocial factors. Journal of General Internal Medicine. 2002, 17:504-511.
8. Ciechanowski PS, Katon WJ, Russo JE: Depression and diabetes: Impact of depressive symptoms on adherence, function, and costs. Archives of Internal Medicine. 2000, 160:3278-3285.
9. Mawhinney H, Spector SL, Heitjan D, et al.: As-needed medication use in asthma usage patterns and patient characteristics. Journal of Asthma. 1993, 30:61-71.
10. Christensen AJ, Ehlers SL, Wiebe JS, et al.: Patient personality and mortality: A 4-year prospective examination of chronic renal insufficiency. Health Psychology. 2002, 21:315-320.
11. Christensen AJ, Smith TW: Personality and patient adherence: Correlates of the five-factor model in renal dialysis. Journal of Behavioral Medicine. 1995, 18:305-313.
12. Christensen AJ, Moran PJ, Wiebe JS: Assessment of irrational health beliefs: Relation to health practices and medical regimen adherence. Health Psychology. 1999, 18:169-176.
13. Isaac IM, Tamblyn RM: Compliance and cognitive function: A methodological approach to measuring unintentional errors in medication compliance in the elderly (McGill-Calgary Drug Research Team). Gerontologist. 1993, 33:772-781.
14. Park DC, Hertzog C, Leventhal H, et al.: Medication adherence in rheumatoid arthritis: Older is wiser. Journal of the American Geriatric Society. 1999, 47:172-183.
15. Dunbar-Jacob J, Burke LE, Rohay JM, et al.: Comparability of self-report, pill count, and electronically monitored adherence data. Controlled Clinical Trials. 1996, 17(25):80S.
16. Hamilton M: A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry. 1960, 23:56-62.
17. Spielberger CD: Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press, 1983.
18. Costa PT, McCrae RR: NEO-PI-R Professional Manual. Odessa, FL: Psychological Assessment Resources, 1992.
19. Sattler JM: Assessment of Children (3rd ed.). San Diego, CA: Sattler, 1988.
20. Wechsler D: Wechsler Adult Intelligence Scale (3rd ed.). New York: Psychological Corporation, 1997.
21. Jarvis PE, Barth JT: The Halstead-Reitan Neuropsychological Battery: A Guide to Interpretation and Clinical Applications. Odessa, FL: Psychological Assessment Resources, 1994.
22. Reitan RM, Wolfson D: The Halstead-Reitan Neuropsychological Test Battery. Tucson, AZ: Neurospsychology Press, 1988.
23. Spreen O, Strauss E (eds): A Compendium of Neuropsychological Tests (2nd ed). New York: Oxford University Press, 1988.
24. Pilkonis PA, Frank E: Personality pathology in recurrent depression: Nature, prevalence and relationship to treatment response. American Journal of Psychiatry. 1988, 145:435-441.
25. Zanarini MC, Frankenburg FR, Dubo ED, et al.: Axis I comorbidity of borderline personality disorder. American Journal of Psychiatry. 1998, 155:1733-1739.
26. Cleveland BL, Denier CA: Recommendations for health care professionals to improve compliance and treatment outcome among patients with cognitive deficits. Issues in Mental Health Nursing. 1998, 19:113-124.
27. Bartlett JA: Addressing the challenges of adherence. Journal of Acquired Immune Deficiency Syndromes. 2002, 29(S1):S2-10.
28. Dunbar-Jacob JM, Schlenk EA, Burke LE, Matthews JT: Predictors of patient adherence: Patient characteristics. In Schumaker SA, Schron EB, Ockene JK, McBee WL (eds), The Handbook of Health Behavior Change (2nd ed). New York: Springer, 1998, 491-511.
29. Christensen AJ: Patient by treatment context interaction in chronic disease: A conceptual framework for the study of patient adherence. Psychosomatic Medicine. 2000, 62:435-443.